Aperio Group’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-16,178
| Closed | -$187K | – | 2358 |
|
2019
Q3 | $187K | Buy |
16,178
+8,417
| +108% | +$97.3K | ﹤0.01% | 2179 |
|
2019
Q2 | $78K | Buy |
+7,761
| New | +$78K | ﹤0.01% | 2455 |
|
2018
Q1 | – | Sell |
-11,032
| Closed | -$146K | – | 2277 |
|
2017
Q4 | $146K | Buy |
11,032
+302
| +3% | +$4K | ﹤0.01% | 2177 |
|
2017
Q3 | $198K | Buy |
+10,730
| New | +$198K | ﹤0.01% | 2124 |
|
2017
Q2 | – | Sell |
-10,296
| Closed | -$232K | – | 2230 |
|
2017
Q1 | $232K | Sell |
10,296
-3,010
| -23% | -$67.8K | ﹤0.01% | 1964 |
|
2016
Q4 | $463K | Buy |
13,306
+3,984
| +43% | +$139K | ﹤0.01% | 1547 |
|
2016
Q3 | $228K | Buy |
+9,322
| New | +$228K | ﹤0.01% | 1876 |
|
2015
Q3 | – | Sell |
-3,218
| Closed | -$222K | – | 2029 |
|
2015
Q2 | $222K | Buy |
+3,218
| New | +$222K | ﹤0.01% | 1803 |
|